References
- Fine PEM, Mulholland K, Scott JA, Edmunds WJ. Community protection in Plotkin’s vaccines. 7th. Elsevier; 2018. p. 1512–31.
- Orenstein WA, Irvin J, Jennings MR, Giandelia J, Halpin TJ, Marks JS, Conrad JL. Measles in a rural Ohio county12. Am J Epidemiol. 1980;111(6):777–89. doi:10.1093/oxfordjournals.aje.a112956.
- Orenstein WA. The role of measles elimination in development of a national immunization program. Pediatr Infect Dis J. 2006;25:1093–101. doi:10.1097/01.inf.0000246840.13477.28.
- Orenstein WA, Hinman AR. The immunization system in the United States – the role of school immunization laws. Vaccine. 1999;17(Suppl 3):S19–S24. doi:10.1016/S0264-410X(99)00290-X.
- Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field. Further Observations Epidemiol Rev. 1988;10:212–41.
- Markowitz LE, Preblud SR, Orenstein WA, Rovira EZ, Adams NC, Hawkins CE, Hinman AR. Patterns of transmission in measles outbreaks in the United States, 1985–1986. N Engl J Med. 1989;320:75–81.
- Hinman AR, Orenstein WA, Rodewald L. Financing immunizations in the United States. Clin Infect Dis. 2004;38(10):1440–46. Epub 2004 Apr 26
- National Vaccine Advisory Committee. The measles epidemic. The problems, barriers, and recommendations. JAMA 1991;266:1547–52.
- DeStefano F. Vaccine safety datalink research group. The vaccine safety datalink project. Pharmacoepidemiol Drug Saf. 2001;10:403–06.
- Orenstein EW, De Serres G, Haber MJ, Shay DK, Bridges CB, Gargiullo P, Orenstein WA. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol. 2007;36(3):623–31. doi:10.1093/ije/dym021.
- National Vaccine Advisory Committee. Enhancing the work of the department of health and human services national vaccine program in global immunization: recommendations of the national vaccine advisory. Public Health Rep. 2014;129(Suppl 3):12–85.
- Plotkin SA, Orenstein WA, Offit PA, Edwards KM. Plotkin’s vaccines. 7th. Elsevier; 2018. p. 1–1691.